Regulatory leadership LSPedia is a leading provider of DSCSA compliance and serialization solutions with recent product launches and enhancements, signaling ongoing commitment to regulatory readiness. This creates opportunities to upsell expanded DSCSA modules and enhanced monitoring to current pharma customers and new clients seeking full compliance coverage.

Product roadmap Recent introductions like OneScan 9.0, Enhanced Suspect Order Monitoring, Serialized Lifecycle Management, Serialized Rev-Cycle Management, and Digital Link indicate an aggressive product trajectory focused on automation, ROI, and interoperability. Use this to position cross-sell of new modules to existing users and target firms planning serialization ROI projects.

Strategic alliances New partnerships with MatchRX and strategic alliances with firms like Fisher Management Partners broaden reach in independent pharmacies and Michigan market. Leverage these relationships to penetrate new segments, co-sell DSCSA compliance, and expand geographic and channel coverage.

Market traction Revenue range of $50M-$100M and a mid-size employee base suggest scalable operations with room for growth through expanded pharma networks, wholesale distributors, dispensers, GPOs, and health systems. Target growth accounts in distributors and health systems seeking unified serialization and cross-platform interoperability.

Expansion opportunities Active customer and partner ecosystem, plus a focus on real-time SOM and ASN/EPCIS integration, opens doors for deployments in hospitals, health systems, and regional distributors. Propose bundled solutions that combine OneScan, Enhanced SOM, and Digital Link for end-to-end traceability and recalls/returns optimization.